Lixte Biotechnology LIXTW Stock
Lixte Biotechnology Price Chart
Lixte Biotechnology LIXTW Financial and Trading Overview
| Lixte Biotechnology stock price | 0.02 USD |
| Previous Close | 0 USD |
| Open | 0.17 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.16 - 0.17 USD |
| 52 Week Range | 0.01 - 0.38 USD |
| Volume | 1.17K USD |
| Avg. Volume | 24.05K USD |
| Market Cap | N/A |
| Beta (5Y Monthly) | 0.892 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
LIXTW Valuation Measures
| Enterprise Value | N/A |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 0.05338164 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Lixte Biotechnology Stock Price History
| Beta (5Y Monthly) | 0.892 |
| 52-Week Change | 4.76% |
| S&P500 52-Week Change | 27.18% |
| 52 Week High | 0.38 USD |
| 52 Week Low | 0.01 USD |
| 50-Day Moving Average | 0.13 USD |
| 200-Day Moving Average | 0.11 USD |
LIXTW Share Statistics
| Avg. Volume (3 month) | 24.05K USD |
| Avg. Daily Volume (10-Days) | 72.55K USD |
| Shares Outstanding | N/A |
| Float | 5.69M |
| Short Ratio | N/A |
| % Held by Insiders | N/A |
| % Held by Institutions | N/A |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | NaN |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | N/A |
| Most Recent Quarter (mrq) | N/A |
| Next Fiscal Year End | N/A |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -68.31% |
| Return on Equity (ttm) | -130.058% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -4133687 USD |
| Diluted EPS (ttm) | N/A |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 2.89M USD |
| Total Cash Per Share (mrq) | 0.51 USD |
| Total Debt (mrq) | 0 USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 10.421 |
| Book Value Per Share (mrq) | 0.414 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -2581395 USD |
| Levered Free Cash Flow (ttm) | -3476484 USD |
Profile of Lixte Biotechnology
| Country | United States |
| State | CA |
| City | Pasadena |
| Address | 680 East Colorado Boulevard |
| ZIP | 91101 |
| Phone | 631 830 7092 |
| Website | https://lixte.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 2 |
Lixte Biotechnology Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on identifying targets for cancer drug development, and developing and commercializing cancer therapies. Its lead product candidate, LB-100 is in phase 1b clinical trials combined with Atezolizumab for patients with microsatellite stable metastatic colorectal cancer. The company's LB-100 combined with doxorubicin in advanced soft tissue sarcoma is under Phase 1b portion; and LB-100 combined with dostarlimab that is in phase 1b/2 for ovarian clear cell carcinoma. The company has a clinical trial research agreement with the Netherlands Cancer Institute; collaboration agreement for an investigator-initiated clinical trial with the Spanish Sarcoma Group; and a development collaboration agreement with the Netherlands Cancer Institute. Lixte Biotechnology Holdings, Inc. was founded in 2005 and is based in Pasadena, California.
Q&A For Lixte Biotechnology Stock
What is a current LIXTW stock price?
Lixte Biotechnology LIXTW stock price today per share is 0.02 USD.
How to purchase Lixte Biotechnology stock?
You can buy LIXTW shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Lixte Biotechnology?
The stock symbol or ticker of Lixte Biotechnology is LIXTW.
Which industry does the Lixte Biotechnology company belong to?
The Lixte Biotechnology industry is Biotechnology.
How many shares does Lixte Biotechnology have in circulation?
The max supply of Lixte Biotechnology shares is 0.
What is Lixte Biotechnology Price to Earnings Ratio (PE Ratio)?
Lixte Biotechnology PE Ratio is now.
What was Lixte Biotechnology earnings per share over the trailing 12 months (TTM)?
Lixte Biotechnology EPS is 0 USD over the trailing 12 months.
Which sector does the Lixte Biotechnology company belong to?
The Lixte Biotechnology sector is Healthcare.